Carcinogenesis

Papers
(The H4-Index of Carcinogenesis is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Editor-In-Chief’s Editorial 202362
Intermittent administration of tacrolimus enhances 
anti-tumor immunity in melanoma-bearing mice41
Genomic profile of radiation-induced early-onset mouse B-cell lymphoma recapitulates features of Philadelphia chromosome-like acute lymphoblastic leukemia in humans39
Identification of biomarkers for the diagnosis and targets for therapy in patients with clear cell ovarian cancer: a systematic literature review33
The putative oncogenic role of WDTC1 in colorectal cancer31
LINC02418 upregulates EPHA2 by competitively sponging miR-372-3p to promote 5-Fu/DDP chemoresistance in colorectal cancer28
Unravelling the distinct biological functions and potential therapeutic applications of TIMP2 in cancer27
miR-1304 targets KLK11 to regulate gastric cancer cell proliferation through the mTOR signaling pathway27
The environmental carcinogen benzo[a]pyrene regulates epigenetic reprogramming and metabolic rewiring in a two-stage mouse skin carcinogenesis model26
Regulatory mechanisms of PFKFB2 in glycolysis and tumor metabolism: implications for cancer therapy26
O-GlcNAcylation of RAB10 promotes hepatocellular carcinoma progression26
Cancer-testis non-coding RNA LEF1-AS1 regulates the nuclear translocation of PDCD5 and suppresses its interaction with p53 signaling: a novel target for immunotherapy in esophageal squamous cell carci25
Identification of HCAR1 as a ferroptosis-related biomarker of gastric cancer based on a novel ferroptosis-related prognostic model and in vitro experiments25
miR-22 promotes immunosuppression via activating JAK/STAT3 signaling in cutaneous squamous cell carcinoma24
Correction to: Triple-negative breast cancer molecular subtypes and potential detection targets for biological therapy indications24
Longitudinal single-cell RNA model aids prediction of EGFR-TKI resistance24
Prognostic value of circulating tumor DNA in different cancer types detected by ultra-low-pass whole-genome sequencing: a systematic review and patient-level survival data meta-analysis24
Redefining pancreatic cancer management with tumor-agnostic precision medicine22
LncRNA LINC02253 activates KRT18/MAPK/ERK pathway by mediating N6-methyladenosine modification of KRT18 mRNA in gastric cancer22
Ehm2 transcript variant 1 inhibits breast cancer progression and increases E-cadherin stability21
Editor-in-Chief’s Note—Thank you to Reviewers20
0.23184990882874